Lyngfelt, L.I.; Erlandsson, M.C.; Nadali, M.; Hedjazifar, S.; Pullerits, R.; Andersson, K.M.; Brembeck, P.; Silfverswärd, S.T.; Smith, U.; Bokarewa, M.I.
Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis. Cells 2021, 10, 1131.
https://doi.org/10.3390/cells10051131
AMA Style
Lyngfelt LI, Erlandsson MC, Nadali M, Hedjazifar S, Pullerits R, Andersson KM, Brembeck P, Silfverswärd ST, Smith U, Bokarewa MI.
Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis. Cells. 2021; 10(5):1131.
https://doi.org/10.3390/cells10051131
Chicago/Turabian Style
Lyngfelt, Lovisa I., Malin C. Erlandsson, Mitra Nadali, Shahram Hedjazifar, Rille Pullerits, Karin M. Andersson, Petra Brembeck, Sofia Töyrä Silfverswärd, Ulf Smith, and Maria I. Bokarewa.
2021. "Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis" Cells 10, no. 5: 1131.
https://doi.org/10.3390/cells10051131
APA Style
Lyngfelt, L. I., Erlandsson, M. C., Nadali, M., Hedjazifar, S., Pullerits, R., Andersson, K. M., Brembeck, P., Silfverswärd, S. T., Smith, U., & Bokarewa, M. I.
(2021). Impact of the Uncoupling Protein 1 on Cardiovascular Risk in Patients with Rheumatoid Arthritis. Cells, 10(5), 1131.
https://doi.org/10.3390/cells10051131